Work

Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer

Year: 2004

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-004-0764-7

Authors: Steven J. Cohen, James Gallo, Nancy L. Lewis, R. Katherine Alpaugh, Louis Gentner, Andr� Rogatko, Gwen Yeslow, Jessie Schol, Tom Verhaeghe, Peter Zannikos, Peter A. Palmer, Louis M. Weiner, Neal J. Meropol

Institutions: Fox Chase Cancer Center, Johnson & Johnson (United States)

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM

OpenAlex ID: W2133311724

FWCI: 0.439

Cites: 16

Cited by: 13

Related to: 10